Works matching IS 14642662 AND DT 2005 AND VI 6 AND IP 5

Results: 12

The effect of combination antiretroviral therapy on CD5 B-cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.

Published in:

2005

By:

Redgrave BE;
Stone SF;
French MAH;
Krueger R;
James IR;
Price P

Publication type:

Journal Article

Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 299, doi. 10.1111/j.1468-1293.2005.00304.x

By:

van den Berg, J. B.;
Hak, E.;
Vervoort, S. C. J. M.;
Hoepelman, I. M.;
Boucher, C. A. B.;
Schuurman, R.;
Schneider, M. M. E.

Publication type:

Article

The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 307, doi. 10.1111/j.1468-1293.2005.00312.x

By:

Redgrave, B. E.;
Stone, S. F.;
French, M. A. H.;
Krueger, R.;
James, I. R.;
Price, P.

Publication type:

Article

HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 313, doi. 10.1111/j.1468-1293.2005.00313.x

By:

Lospitao, E.;
Álvarez, A.;
Soriano, V.;
Holguín, A.

Publication type:

Article

Laser scanning as a tool for assessment of HIV-related facial lipoatrophy: evaluation of accuracy and reproducibility.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 321, doi. 10.1111/j.1468-1293.2005.00314.x

By:

Yang, Y.;
Paton, N. I.

Publication type:

Article

Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 326, doi. 10.1111/j.1468-1293.2005.00316.x

By:

Rimland, D.;
Guest, J. L.;
Hernández, I.;
del Rio, C.;
Le, N. A.;
Brown, W. V.

Publication type:

Article

The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1250 mg twice-daily regimen in HIV-infected patients.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 334, doi. 10.1111/j.1468-1293.2005.00317.x

By:

Justesen, U. S.;
Hansen, I. M.;
Andersen, Å;
Klitgaard, N. A.;
Black, F. T.;
Gerstoft, J.;
Mathiesen, L. R.;
Pedersen, C.

Publication type:

Article

The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 341, doi. 10.1111/j.1468-1293.2005.00318.x

By:

Parsonage, M. J.;
Wilkins, E. G. L.;
Snowden, N.;
Issa, B. G.;
Savage, M. W.

Publication type:

Article

Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 347, doi. 10.1111/j.1468-1293.2005.00319.x

By:

Henderson, M.;
Safa, F.;
Easterbrook, P.;
Hotopf, M.

Publication type:

Article

A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 353, doi. 10.1111/j.1468-1293.2005.00320.x

By:

Arranz Caso, J. A.;
López, J. C.;
Santos, I.;
Estrada, V.;
Castilla, V.;
Sanz, J.;
Molina, J. P.;
Fernández Guerrero, M.;
Górgolas, M.

Publication type:

Article

Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 366, doi. 10.1111/j.1468-1293.2005.00322.x

By:

Fairley, C. K.;
Permana, A.;
Read, T. R. H.

Publication type:

Article

Clinical benefit of interventions driven by therapeutic drug monitoring.

Published in:

HIV Medicine, 2005, v. 6, n. 5, p. 360, doi. 10.1111/j.1468-1293.2005.00321.x

By:

Rendón, A. L.;
Núñez, M.;
Jiménez-Nácher, I.;
González de Requena, D.;
González-Lahoz, J.;
Soriano, V.

Publication type:

Article